Default: The Lancet Haematology

ISSN:

Journal Home

Journal Guideline

The Lancet Haematology Q1 Unclaimed

Lancet Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The Lancet Haematology is a journal indexed in SJR in Hematology with an H index of 54. It has an SJR impact factor of 5,343 and it has a best quartile of Q1. It has an SJR impact factor of 5,343.

The Lancet Haematology focuses its scope in these topics and keywords: duration, elastic, therapy, rituximab, prevention, postthrombotic, compression, treatment, syndrome, standard, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Hematology (Q1)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

The Lancet Haematology

5,343

SJR Impact factor

54

H Index

206

Total Docs (Last Year)

379

Total Docs (3 years)

3676

Total Refs

1917

Total Cites (3 years)

150

Citable Docs (3 years)

5,4

Cites/Doc (2 years)

17,84

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


duration, elastic, therapy, rituximab, prevention, postthrombotic, compression, treatment, syndrome, standard, lymphoma, cohort, costeffectiveness, shortened, oral, outcome, intravenous, interim, combined, direct, era, european, failure, firstline, follicular, hodgkins, immunotherapy,

FAQS